Pier Luigi Zinzani, MD, PhD¹, Muhit Özcan², Marcelo Capra, MD, PhD³, Armando Santoro, MD^4,5*, Panayiotis Panayiotidis, MD⁶, Krimo Bouabdallah, MD^7*, Wojciech Jurczak⁸, Charles Phelps, MS^9*, Florian JR Hiemeyer, MSc^10*, Lidia Mongay Soler^11*, Jose Garcia-Vargas, MD^11*, Barrett H. Childs¹¹, Georg Lenz, MD, Prof.¹², Matthew J. Matasar, MD, MS¹³ and Martin Dreyling, MD¹⁴

¹IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seragnoli”Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale Università di Bologna, Bologna, Italy
²Ankara University School of Medicine, Ankara, Turkey
³Hospital do Cancer Mae de Deus, Porto Alegre, PB, Brazil
⁴Department of Biomedical Sciences, Humanitas University, Milan, Italy
⁵IRCCS Humanitas Research Hospital - Humanitas Cancer Center Rozzano, Milan, Italy
⁶First Propedeutic Department of Internal Medicine, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
⁷University Hospital of Bordeaux, Bordeaux, France
⁸Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland
⁹Bayer HealthCare Pharmaceuticals, Inc, Whippany, NJ
¹⁰Pharmaceutical Division, Bayer AG, Berlin, Germany
¹¹Bayer HealthCare Pharmaceuticals, Inc., Whippany, NJ
¹²Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany
¹³215 West 90th St, 14E, Memorial Sloan Kettering Cancer Center, New York, NY
¹⁴Department of Medicine III, University Hospital, LMU Munich, Munich, Germany

Anne Ségolène Cottereau, MD, PhD^1*, Louis Rebaud^2*, Judith Trotman, FRACP³, Pierre Feugier, MD, PhD^4*, Loretta J. Nastoupil, MD⁵, Emmanuel Bachy, MD, PhD^6*, Ian W. Flinn, MD PhD⁷, Corinne Haioun, MD, PhD⁸, Loic Ysebaert, MD, PhD^9*, Nancy L. Bartlett, MD¹⁰, Hervé Tilly, MD, PhD¹¹, René-Olivier Casasnovas, MD, PhD^12*, Romain Ricci^13*, Cedric Portugues^14*, Irène Buvat, PhD^15*, Michel Meignan, MD, PhD^16,17* and Franck Morschhauser, MD, PhD^18*

¹Department of Nuclear Medicine, Cochin University Hospital, AP-HP, Paris, France
²Laboratoire D'Imagerie Translationnelle En Oncologie, Institut Curie, U1288 Inserm, Paris, FRA
³Department of Haematology, Concord Hospital, Concord, NSW, Australia
⁴Hematology Department, University Hospital of Nancy, Vandoeuvre, France
⁵Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX
⁶Department of Hematology, Hospices Civils de Lyon, Lyon Sud University Hospital, Pierre Benite, France
⁷Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN
⁸Lymphoid Malignancies Department, Henri Mondor University Hospital/Assistance Publique-Hôpitaux de Paris (AP-HP)/Université Paris-Est Créteil (UPEC), Creteil, France
⁹Hematology Department, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France
¹⁰Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO
¹¹Centre Henri Becquerel, Rouen, France
¹²Hématologie Clinique, CHU Dijon Bourgogne, Dijon, France
¹³LYSARC, The Lymphoma Academic Research Organisation, Créteil, FRA
¹⁴Centre Hospitalier Lyon-Sud, LYSARC, The Lymphoma Academic Research Organisation, Lyon, France
¹⁵LITO laboratory, UMR 1288 Inserm, Institut Curie, University Paris Saclayr, Orsay, France
¹⁶CHU de Henri Mondor, Créteil, France
¹⁷LYSA, Paris, France
¹⁸Service des Maladies du Sang, CHU Lille, Lille, France

Michael Wang, MD¹, Tadeusz Robak², Kami J. Maddocks, MD³, Tycel Phillips, MD^4*, Stephen D. Smith, MD⁵, David Gallinson, DO^6*, Roser Calvo^7*, Chuan-Chuan Wun, RPh, PhD^8*, Veerendra Munugalavadla⁸ and Wojciech Jurczak⁹

¹MD Anderson Cancer Center, University of Texas, Houston, TX
²Copernicus Memorial Hospital, Medical University of Lodz, Lodz, Poland
³The James Comprehensive Cancer Center, The Ohio State University, Columbus, OH
⁴University of Michigan Comprehensive Cancer Center, Ann Arbor, MI
⁵University of Washington/Fred Hutchinson Cancer Research Center, Seattle
⁶Summit Medical Group, Florham Park, NJ
⁷AstraZeneca, Gaithersburg, MD
⁸AstraZeneca, South San Francisco, CA
⁹MSC National Research Institute of Oncology, Krakow, Poland

Frederique St-Pierre, MD¹, Stephen Broski, MD^2*, Zequn Sun^3*, Masha Kocherginsky^4*, Andrew Quon, MD^5*, Lucia Baratto, MD^6*, Hatice Savas, MD^7*, Lale Kostakoglu, MD, MPH^8*, Jane N. Winter, MD⁹, Thomas E. Witzig, MD¹⁰, Brad S. Kahl, MD¹¹, Andrew Matthew Evens, DO, MBA, MMSc¹² and Leo I. Gordon, MD¹³

¹Northwestern University Feinberg School of Medicine and the Robert H. Lurie Comprehensive Cancer Center, Chicago, IL
²Mayo Clinic, Rochester, MN
³Department of Preventive Medicine, Division of Biostatistics, Northwestern University Feinberg School of Medicine and the Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago
⁴Northwestern University Feinberg School of Medicine and the Robert H. Lurie Comp, Chicago, IL
⁵Medical Center, Univerisity of California, Los Angelos, CA
⁶Nuclear Medicine and Molecular Imaging Division, Stanford Cancer Institute, Stanford
⁷Department of Radiology, Northwestern University, Chicago, IL
⁸University of Virginia, Charlottesville, VA
⁹Feinberg School of Medicine, Northwestern University, Division of Hematology/Oncology, Robert H. Lurie Comprehensive Cancer Center, Chicago, IL
¹⁰Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
¹¹Division of Oncology, Washington University School of Medicine in St. Louis, Saint Louis, MO
¹²Rutgers Cancer Institute of New Jersey, Warren, NJ
¹³Department of Medicine, Division of Hematology/Oncology and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Northwestern University Feinberg School of Medicine, Chicago, IL

Andrés José María J.M. Ferreri, MD¹, Marianna C. Sassone, MD^2*, Maria Giulia Cangi^3*, Gilda Magliacane^4*, Stefania Zanussi^5*, Elena Flospergher^6*, Fabrizio Marino^6*, Lucia Bongiovanni, MD^4*, Marco Ladetto, MD⁷, Federica Cavallo, MD^8,9*, Franco Aversa, MD^10*, Antonella Anastasia, MD^11*, Donato Mannina, MD^12*, Anna Pascarella^13*, Daniele Vallisa¹⁴, Alessandro Pulsoni^15*, Luisella Bonomini^16*, Francesco Bertoni, MD^17,18, Riccardo Dolcetti^19*, Emanuele Zucca, MD^20,21,22 and Maurilio Ponzoni, MD²³

¹IRCCS San Raffaele Scientific Institute, Milano, Italy
²Lymphoma Unit, Department of Onco-Hematology, IRCCS San Raffaele Scientific Institute, Milan, Italy
³Pathology Unit, IRCCS San Raffaele Scientific Institute, Milano, ITA
⁴Pathology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy
⁵Immunopathology and Cancer Biomarkers Unit, IRCCS National Cancer Institute, Aviano, Italy
⁶Lymphoma Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy
⁷Division of Hematology, Department of Molecular Biotechnologies and Health Sciences, University of Torino/AOU Città della Salute e della Scienza di Torino, Turin, Italy
⁸Department of Molecular Biotechnologies and Health Sciences, Division of Hematology, University of Torino, Turin, Italy
⁹Division of Hematology , AOU Città della Salute e della Scienza di Torino, Torino, Italy
¹⁰Emaologia e Centro Trapianti Midollo Osseo, Azienda Ospedaliero Universitaria di Parma, Parma, Italy
¹¹Department of Hematology, ASST Spedali Civili, Brescia, Italy
¹²Oncology-Hematology Department, Papardo Hospital, Messina, Italy
¹³U.O. Ematologia, Ospedale dell'Angelo, Mestre-Venezia, Italy
¹⁴Dipartimento di oncologia ed ematologia, Guglielmo da Saliceto Hospital, Piacenza, Italy
¹⁵Hematology Section, Department of Translational and Precision Medicine, Sapienza University of Rome, Italy, Rome, Italy
¹⁶International Extranodal Lymphoma Study Group, Foundation for the Institute of Oncology Research, Bellinzona, Switzerland
¹⁷Università della Svizzera Italiana - Faculty of Biomedical Sciences, Bellinzona, Switzerland
¹⁸Institute of Oncology Research (IOR), Bellinzona, Switzerland
¹⁹Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Australia
²⁰Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland
²¹Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland
²²International Extranodal Lymphoma Study Group, Institute of Oncology Research, Bellinzona, Switzerland
²³Pathology Unit, Ateneo Vita-Salute San Raffaele University, Milan, Italy

Eva Laverdure, MD, Vincent Ethier, MD, BSc, Josie-Anne Boisjoly, MD^*, Melanie Desaulniers, MD^* and Eric Turcotte, MD^*

Sherbrooke University Hospital Center, Sherbrooke, QC, Canada

Jonathon B. Cohen, MD, MS¹, Opeyemi Jegede, PhD^2*, Craig A. Portell, MD³, Mehdi Hamadani, MD⁴, Catherine S. Diefenbach, MD⁵, Kevin A. David, MD⁶, Christopher D. Fletcher, MD^7*, Daniel J. Landsburg, MD⁸, Suparna Mantha, MD^9* and Brad S. Kahl, MD¹⁰

¹Winship Cancer Institute, Department of Hematology and Medical Oncology, Emory University, Atlanta, GA
²Dana Farber Cancer Institute, ECOG-ACRIN Biostatistics Center, Boston
³Division of Hematology and Oncology, Department of Medicine, University of Virginia, Charlottesville, VA
⁴The BMT & Cellular Therapy Program, Medical College of Wisconsin, Milwaukee, WI
⁵New York University School of Medicine, NYU Cancer Institute, New York, NY
⁶Cancer Institute of New Jersey, New Brunswick, NJ
⁷University of Wisconsin Hospital & Clinics, Madison, WI
⁸Division of Hematology/Oncology, University of Pennsylvania, Philadelphia, PA
⁹Carle Cancer Center, Urbana, IL
¹⁰Division of Oncology, Washington University School of Medicine in St. Louis, Saint Louis, MO

Reema K. Tawfiq^1*, Melissa C. Larson, MS^2,3,4*, Jennifer Jane Gile, MD¹, Allison M. Bock, MD⁵, Kittika Poonsombudlert, MD⁶, Seth M. Maliske, MD^7,8, Matthew J. Maurer, DSc⁹, James R. Cerhan, MD, PhD², Brian Kabat, B.S.^10*, Katherine Smith^1*, Richard Curtis Godby, MD¹¹, Jonas Paludo, MD^5,12, David J. Inwards, MD¹², Sabarish Ayyappan, MBBS¹³, Stephen M. Ansell, MD, PhD⁵, Thomas M. Habermann, MD¹², Thomas E. Witzig, MD⁵, Grzegorz S. Nowakowski, MD⁵, Umar Farooq, MD⁸ and Yucai Wang, MD, PhD^5,12

¹Mayo Clinic, Rochester, MN
²Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
³Bistatistics, Mayo Clinic, Rochester, MN
⁴Department of Health Sciences Research, Mayo Clinic, Rochester, MN
⁵Division of Hematology, Mayo Clinic, Rochester, MN
⁶University of Iowa Hospital and Clinics, Iowa City, IA
⁷Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa Hospital and Clinics, Iowa City, IA
⁸Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA
⁹Division of Clinical Trial and Biostatistics, Mayo Clinic, Rochester, MN
¹⁰Division of Biomedical Statistics & Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, MN
¹¹Division of Hematology, Mayo Clinic, Rochester, MN, USA, Rochester, MN
¹²Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
¹³Division of Hematology, Oncology and Blood and Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA

Adam J. Olszewski, MD¹, Scott F. Huntington, MD, MPH², Rajat Bannerji, MD, PhD³, Thomas A. Ollila, MD⁴, Jessica McMahon, RN-BSN, OCN^5* and Patrycja M Dubielecka, PhD⁶

¹Lifespan Cancer Institute, Alpert Medical School of Brown University, Providence, RI
²Yale Cancer Center, Yale University School of Medicine, New Haven, CT
³Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
⁴Lifespan Cancer Institute, Brown University, Providence, RI
⁵Lifespan Oncology Clinical Research, Rhode Island Hospital, Providence, RI
⁶Division of Hematology-Oncology, Warren Alpert Medical School of Brown University/Rhode Island Hospital, Providence, RI

Kerry A. Rogers, MD¹, Eric McLaughlin, MS^2*, Lai Wei, PhD^2*, Mirela Iulia Anghelina, MD, MPH^3*, Mir Khader Ali, BS^4*, Leslie A. Andritsos, MD⁵, Evgeny Arons^6*, James S. Blachly, MD¹, Timothy G. Call, MD⁷, S. Percy Ivy, MD^8*, Lacey James-Echenique, CRNP^6*, Jeffrey A. Jones, MD, MPH¹, Robert J. Kreitman⁶, Gerard Lozanski, MD⁹, Farhad Ravandi, MD¹⁰, Charles A. Schiffer, MD¹¹, William E. Carson III, MD^12* and Michael R. Grever, MD¹

¹Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
²Center for Biostatistics, The Ohio State University, Columbus, OH
³Department of Biomedical Informatics, The Ohio State University, Columbus, OH
⁴Comprehensive Cancer Center, The Ohio State University, Columbus, OH
⁵Comprehensive Cancer Center, University of New Mexico, Albuquerque, NM
⁶Laboratory of Molecular Biology, National Cancer Institute, NIH, Bethesda, MD
⁷Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
⁸National Cancer Institute Cancer Therapy Evaluation Program, Rockville, MD
⁹Department of Pathology, The Ohio State University, Columbus, OH
¹⁰Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
¹¹Department of Oncology, Karmanos Cancer Institute at Wayne State University, Detroit, MI
¹²Division of Surgical Oncology, Department of Surgery and Comprehensive Cancer Center, The Ohio State University, Columbus, OH

Jun Zhu, MD^1*, Yuqin Song, MD¹, Jianyong Li, MD², Keshu Zhou^3*, Xiaoyan Ke, MD^4*, Zhen Cai, PhD, MD^5*, Huilai Zhang, MD^6*, Tingting Yao, MS^7*, Zhen Xia, MS^7*, Yiqiu Wang, MD^7*, Peiqiong Lai, MPH^7* and Xiaofeng Liu, MS^7*

¹Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute, Beijing, China
²The First Affiliated Hospital With Nanjing Medical University, Nanjing, China
³Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China
⁴Department of Hematology, Peking University Third Hospital, Beijing, China
⁵Department of Hematology, The First Affiliated Hospital of Medical College, Zhejiang University, Hangzhou, China
⁶Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
⁷AstraZeneca, Shanghai, China

Felipe Samaniego, MD¹, Ahad A. Sadiq, MD^2*, Daruka Mahadevan, MD, PhD³, Michael Z. Koontz, MD⁴, Jose C. Villasboas, MD⁵, John M. Burke, MD⁶, Erin G Reid, MD, MS⁷, Mohamad Cherry, MD, MS⁸, Jason Melear, MD⁹, Victor Priego, MD^10*, Patrick Cobb, MD¹¹, Elizabeth H. Cull, MD¹², Paul Conkling, MD^13*, David Cosgrove, MD^14*, Lindsey Roeker, MD¹⁵, Donna Nguyen Haney^16*, Jia Hu, PhD^17*, Ranjeet Kumar Sinha, PhD^17*, William G Rice, PhD¹⁶ and Rafael Bejar, MD, PhD^7,16,18

¹Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
²Fort Wayne Medical Oncology, Fort Wayne, IN
³University of Texas Health, San Antonio, Mays Cancer Center, San Antonio, TX
⁴Pacific Cancer Care, Morgan Hill, CA
⁵Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN
⁶US Oncology Hematology Research Program, Rocky Mountain Cancer Centers, Aurora, CO
⁷Moores Cancer Center, University of California, San Diego, La Jolla, CA
⁸Hematology and Medical Oncology, Morristown Medical Center, Morristown, NJ
⁹Texas Oncology-Austin Midtown, Austin, TX
¹⁰Regional Cancer Care Associates, Hackensack, NJ
¹¹St. Vincent Frontier Cancer Center, Billings, MT
¹²GHS Cancer Institute, Greenville, SC
¹³Virginia Oncology Associates, Norfolk, VA
¹⁴Northwest Cancer Specialists / Compass Oncology, Vancouver, WA
¹⁵Memorial Sloan Kettering Cancer Center, New York, NY
¹⁶Aptose Biosciences, Inc., San Diego, CA
¹⁷Aptose Bioscience Inc, San Diego, CA
¹⁸Division of Hematology and Oncology, University of California San Diego Moores Cancer Center, La Jolla, CA

Yuqin Song, MD¹, Keshu Zhou^2*, Dehui Zou^3*, Dengju Li^4*, Jianda Hu⁵, Haiyan Yang^6*, Huilai Zhang^7*, Jie Ji⁸, Wei Xu⁹, Jie Jin, PhD¹⁰, Fangfang Lv^11*, Ru Feng¹², Sujun Gao^13*, Daobin Zhou^14*, Constantine S. Tam, MD, MBBS¹⁵, David Simpson¹⁶, Michael L. Wang, MD¹⁷, Tycel J. Phillips, MD¹⁸, Stephen Opat¹⁹, Cheng Fang^20*, Shaohui Sun^20* and Jun Zhu, PhD²¹

¹Peking University Cancer Hospital & Institute, Beijing, China
²Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China
³State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical Colleg, Tianjin, China
⁴Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
⁵Fujian Medical University Union Hospital, Fuzhou, Fujian, China
⁶The Cancer Hospital of the University of Chinese Academy of Sciences（Zhejiang Cancer Hospital），Institute of Basic Medicine and Cancer（IBMC），Chinese Academy of Sciences, Hangzhou, China
⁷Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
⁸West China Hospital of Sichuan University, Chengdu, China
⁹The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China
¹⁰The First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, China
¹¹Fudan University Shanghai Cancer Center, Shanghai, China
¹²Nanfang Hospital of Southern Medical University, Guangzhou, China
¹³The First Hospital of Jilin University, Changchun, China
¹⁴Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
¹⁵Peter MacCallum Cancer Centre, St. Vincent’s Hospital, University of Melbourne, Melbourne, Australia
¹⁶North Shore Hospital, Auckland, New Zealand
¹⁷MD Anderson Cancer Center, Houston, TX
¹⁸University of Michigan Medical School, Ann Arbor, MI
¹⁹Monash Health, Monash University, Clayton, Australia
²⁰BeiGene (Beijing) Co., Ltd., BeiJing, China
²¹Peking University Cancer Hospital and Institute, Beijing, China

Antonio Pinto, MD^1*, Emanuele Guardalben^2*, Marica Battista^2*, Giulia Chiara Gazzoli^2*, Michele Merli, MD^3*, Annalisa Chiarenza^4*, Tommasina Perrone^5*, Attilio Guarini, MD^6*, Nicola Di Renzo, MD^7*, Carlo Visco, MD^8*, Agostino Tafuri⁹, Roberta Murru^10*, Felicetto Ferrara, MD^11*, Jacopo Olivieri^12*, Attilio Olivieri, MD^13*, Andrés J M Ferreri, MD¹⁴, Marco Ladetto, MD^15,16, Pier Luigi Zinzani, MD, PhD^17,18, Luca Arcaini, MD^19,20* and Giuseppe Gritti^21*

¹Hematology-Oncology & Stem Cell Transplantation Unit, National Cancer Institute, Fondazione Pascale, IRCCS, Naples, Italy
²Roche S.p.A., Monza, Italy
³University Hospital "Ospedale di Circolo e Fondazione Macchi" - ASST Sette Laghi, University of Insubria, Varese, Italy
⁴AOU Policlinico G.Rodolico, Catania, Italy
⁵Hematology Unit, University of Bari "Aldo Moro", Bari, Italy
⁶Hematology and Cell Therapy Unit, IRCCS Istituto Tumori 'Giovanni Paolo II', Bari, Italy
⁷"Vito Fazzi" Hospital, Lecce, Italy
⁸University of Verona, Verona, ITA
⁹University Hospital Sant'Andrea-Sapienza, Rome, Italy
¹⁰Hospital A. Businco, ARNAS “G. Brotzu”, Cagliari, CAGLIARI, Italy
¹¹+390817472241, Napoli, Italy
¹²Azienda Sanitaria Universitaria Integrata Santa Maria della Misericordia, Udine, Italy
¹³Azienda Ospedali Riuniti di Ancona, Ancona University, Ancona, Italy
¹⁴IRCCS San Raffaele Scientific Institute, Milano, Italy
¹⁵Università del Piemonte Orientale, Alessandria, Italy
¹⁶Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria, ITA
¹⁷University of Bologna, Bologna, Italy
¹⁸IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seragnoli”Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale Università di Bologna, Bologna, Italy
¹⁹University of Pavia, Pavia, Italy
²⁰Division of Hematology and Department of Molecular Medicine, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
²¹Ospedale Papa Giovanni XXIII, Bergamo, ITA

Shayna Sarosiek, MD¹, Helmut G Rennke, MD^2*, Catherine A. Flynn, NP^3*, Christopher T Doughty, MD^4*, Andrew R. Branagan, MD⁵, Steven P Treon, MD, PhD¹ and Jorge J. Castillo, MD³

¹Dept. of Medical Oncology, Dana Farber Cancer Institute and Harvard Medical School, Bing Center for Waldenström Macroglobulinemia, Boston, MA
²Department of Pathology, Brigham & Women's Hospital, Boston, MA
³Bing Center for Waldenstrom's macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA
⁴Brigham & Women's Hospital, Boston, MA
⁵Hematology and Oncology Division, Massachusetts General Hospital, Boston, MA

David A. Bond, MD, BS¹, Jason T. Romancik, MD², Jeffrey M. Switchenko, PhD, MS^3*, Brielle Berkowitz^4*, Jonathan R Day, MD, PharmD⁵, Umar Farooq, MD⁶, Sabarish Ayyappan, MBBS⁷, Katelin Baird, BS^8*, Michelle L. Churchman, PhD^9*, Andrew M. Evens, DO, MBA, MMSc¹⁰, Bijal D. Shah, MD¹¹, Craig A. Portell, MD¹², Kami J. Maddocks, MD¹³, Brian K. Link, MD⁶, Jonathon B. Cohen, MD, MS¹⁴ and Deborah M. Stephens, DO¹⁵

¹Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
²Department of Hematology and Medical Oncology, Winship Cancer Institute at Emory University, Atlanta, GA
³Departments of Biostatistics and Bioinformatics, Emory University School of Medicine, Atlanta, GA
⁴Emory University, Atlanta, GA
⁵Department of Internal Medicine, University of Iowa Carver College of Medicine, North Liberty, IA
⁶Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA
⁷Division of Hematology, Oncology and Blood and Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA
⁸Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA
⁹M2GEN, Hudson, FL
¹⁰Rutgers Cancer Institute of New Jersey, Warren, NJ
¹¹H. Lee Moffitt Cancer Center, Tampa, FL
¹²Division of Hematology and Oncology, Department of Medicine, University of Virginia, Charlottesville, VA
¹³Division of Hematology, Department of Internal Medicine, The James Cancer Hospital at The Ohio State University, Columbus, OH
¹⁴Department of Hematology and Medical Oncology, Emory University, Atlanta, GA
¹⁵Huntsman Cancer Institute, Salt Lake City, UT

Shuhua Yi, MD^*, Yi Wang^*, Yuting Yan^*, Jiawen Chen^*, Wei Liu^*, Tingyu Wang^*, Gang An, MD^*, Weiwei Sui^*, Wenyang Huang, MD^*, Xiong Wenjie^*, Huimin Liu^*, Qi Sun^*, Huijun Wang^*, Zhijian Xiao, MD&PhD^*, Jianxiang Wang, MD, Dehui Zou^* and Lugui Qiu

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical Colleg, Tianjin, China

Johanna A.A. Bult, BSc^1*, Francien Huisman^2*, Yujie Zhong, MSc^3*, Nick Veltmaat, MSc^2*, Sanne Tonino^4*, Joost S.P. Vermaat, MD, PhD⁵, Martine E.D. Chamuleau, MD, PhD⁶, Arjan Diepstra, M.D., Ph.D.⁷, Wouter J. Plattel, MD PhD^8*, Anke Van Den Berg, PhD⁷, Mirian Brink, PhD^9* and Marcel Nijland, MD, PhD^10*

¹Department of Hematology, University Medical Center Groningen, Groningen, Netherlands
²Department of Hematology, Groningen, Netherlands
³Department of Pathology and Medical Biology, Groningen, Netherlands
⁴Dept of Hematology, Lymmcare, Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands
⁵Department of Hematology, Leiden University Medical Center, Leiden, Zuid-Holland, Netherlands
⁶Amsterdam UMC, Vrije Universiteit Amsterdam, department of Hematology, Cancer Center Amsterdam, Amsterdam, Netherlands
⁷Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands
⁸Department of Hematology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands
⁹Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands, Utrecht, Netherlands
¹⁰Department of Hematology, University Medical Center Groningen and University of Groningen, Groningen, Netherlands

Jennifer Jane Gile, MD¹, Allison M. Bock, MD², Reema K. Tawfiq^1*, Melissa C. Larson, MS^3*, Kittika Poonsombudlert, MD⁴, Seth M. Maliske, MD⁵, Matthew J. Maurer, DSc³, James R. Cerhan, MD, PhD³, Brian Kabat, B.S.^6*, Brianna Gysbers^1*, Katherine Smith^1*, Steven R Hwang, MD², David J. Inwards, MD⁷, Jonas Paludo, MD⁷, Stephen M. Ansell, MD, PhD², Thomas M. Habermann, MD², Sabarish Ayyappan, MBBS⁸, Thomas E. Witzig, MD⁷, Grzegorz S. Nowakowski, MD², Umar Farooq, MD^9,10,11,12 and Yucai Wang, MD, PhD⁷

¹Mayo Clinic, Rochester, MN
²Division of Hematology, Mayo Clinic, Rochester, MN
³Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
⁴University of Iowa Hospital and Clinics, Iowa City, IA
⁵Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa Hospital and Clinics, Iowa City, IA
⁶Division of Biomedical Statistics & Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, MN
⁷Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
⁸The Ohio State University James Comprehensive Cancer Center, Columbus, OH
⁹University of Iowa, Iowa City, IA
¹⁰Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA
¹¹Division of Hematology, Oncology, Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA
¹²University of Iowa Carver College of Medicine, Iowa City, IA

Mateo Sarmiento Bustamante^1*, Sheila K Pierson, MSc^1*, Yue Ren^2*, Daisy Alapat^3*, Adam Bagg, MD⁴, Joshua D Brandstadter, MD, PhD, MSc⁵, Mary Jo Lechowicz, MD⁶, Hongzhe Lee, PhD^2*, Gordan Srkalovic, MD, PhD⁷, Megan S. Lim, MD, PhD⁴, Frits van Rhee⁸ and David C Fajgenbaum, MD, MBA, MSc¹

¹Center for Cytokine Storm Treatment & Laboratory, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
²University of Pennsylvania, Philadelphia, PA
³UAMS, Little Rock, AR
⁴Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA
⁵Division of Hematology and Oncology, Abramson Cancer Center University of Pennsylvania, SWARTHMORE, PA
⁶Hematology & Medical oncology, Emory University School of Medicine, Atlanta, GA
⁷Sparrow Herbert-Herman Cancer Center, Lansing, MI
⁸Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR

Daniel Rosas, MD¹, Daniela Urueta, MD^2*, Qianqian Liu, PhD^3,4*, Joel E Michalek, PhD^3* and Adolfo Enrique Diaz Duque, MD^5,6

¹Mays Cancer Center, University of Texas Health Science Center at San Antonio, San Antonio, TX
²University of Texas Health San Antonio, San Antonio, TX
³Hematology-Oncology Division, UT Health San Antonio / Mays Cancer Center, San Antonio, TX
⁴Department of Epidemiology and Biostatistics, University of Texas Health Science Center at San Antonio, San Antonio, TX
⁵University of Texas Health San Antonio MD Anderson Cancer Center, San Antonio, TX
⁶Hematology-Oncology Division, Associate Professor, San Antonio, TX

Andrew Stiff, MD, PhD¹, Qiuhong Zhao, MS^2*, Nilesh Kapoor, BA³, Kerry A. Rogers, MD⁴, Mirela Iulia Anghelina, MD, MPH^2*, Jasmine Neal, MPH^2*, Leslie A. Andritsos, MD⁵, James S. Blachly, MD⁶, Gerard Lozanski, MD⁷, Michael R. Grever, MD⁸ and Seema A. Bhat, MD²

¹Division of Hematology, Department of Internal Medicine, Ohio State University, Columbus, OH
²Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
³College of Medicine, The Ohio State University, Columbus, OH
⁴Department of Internal Medicine, Division of Hematology, College of Medicine, The Ohio State University, Columbus, OH
⁵University of New Mexico Comprehensive Cancer Center, Albuquerque, NM
⁶Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH
⁷Department of Pathology, The Ohio State University, Columbus, OH
⁸Department of Internal Medicine, Division of Hematology, Wexner Medical Center at Ohio State University, Columbus, OH

Alessandro Broccoli^1*, Lisa Argnani, PhD^2*, Laura Nanni, MD^1*, Gianmarco Bagnato^1*, Matteo Carella^1*, Beatrice Casadei^1*, Paolo Elia Coppola^1*, Gabriele Gugliotta, MD, PhD³, Ginevra Lolli^1*, Marianna Gentilini^1*, Alice Morigi^1*, Cinzia Pellegrini^4*, Vittorio Stefoni, MD^1* and Pier Luigi Zinzani, MD, PhD¹

¹Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy
²Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology L. e A. Seràgnoli, University of Bologna, Bologna, Italy
³Istituto di Ematologia “Seràgnoli", IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
⁴IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Bologna, ITA

Annamaria Frustaci^1*, Francesco Piazza, MD², Simone Ferrero, MD³, Gianluigi Reda, MD^4*, Rita Rizzi, MD^5*, Lorella Orsucci, MD^6*, Isacco Ferrarini^7*, Marina Deodato, MD^1*, Luca Laurenti, MD^8*, Benedetta Puccini, MD^9*, Claudia Baratè, MD^10*, Marzia Varettoni, MD^11*, Michele Merli, MD^12*, Emanuele Cencini, MD^13*, Antonino Greco, MD^14*, Guido Gini, MD¹⁵, Angela Ferrari, MD^16*, Chiara Borella, MD^17*, Enrico Lista, MD^18*, Massimo Gentile, MD^19*, Roberta Murru, MD^20*, Marina Motta, MD^21*, Francesca Rezzonico, MD^22*, Monica Tani, MD^23*, Paolo Sportoletti, MD^24*, Giulia Zamprogna, MD^1*, Valter Torri^25*, Roberto Cairoli^26* and Alessandra Tedeschi^1*

¹ASST Grande Ospedale Metropolitano Niguarda, Niguarda Cancer Center, Department of Hematology, Milano, Italy
²Department of Medicine, University of Padova, Padua, Italy
³Hematology Division I, Department of Molecular Biotechnologies and Health Sciences/Division of Hematology 1 U, University of Turin/University Hospital A.O.U. “Città della Salute e della Scienza”, Turin, Italy
⁴Hematology unit, Hematology Unit, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico of Milan, Milan, Italy
⁵Department of Emergency and Organ Transplantation University of Bari "Aldo Moro", Bari, Italy
⁶Division of Hematology, Azienda Ospedaliera e Universitaria Città della Salute e della Scienza, Torino, Italy
⁷Department of Medicine, Section of Hematology and Bone Marrow Trasplant Unit, University of Verona, Verona, Italy
⁸Sezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche, Università Cattolica del Sacro Cuore, Rome, Italy
⁹Careggi University Hospital, Firenze, Italy
¹⁰Department of Clinical and Experimental Medicine, Section of Hematology, University of Pisa, Pisa, Italy
¹¹Division of Hematology Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
¹²Hematology, Ospedale di Circolo e Fondazione Macchi, Varese, Italy
¹³Division of Hematology, Azienda Ospedaliera Universitaria Senese and University of Siena, Siena, Italy
¹⁴Ospedale Cardinale Giovanni Panico, Tricase, Italy
¹⁵Hematology, Department of Clinical and Molecular Sciences, Azienda Ospedaliera Universitaria Ospedali Riuniti, Ancona, Italy
¹⁶Hematology, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy
¹⁷Division of Haematology, Ospedale San Gerardo, Monza, Italy
¹⁸Hematology unit, Hospital of Trento, Trento, Italy
¹⁹Hematology Unit AO Cosenza, Cosenza, Italy
²⁰Hematology and Stem Cell Transplantation Unit, Ospedale Oncologico A. Businco, ARNAS G. Brotzu, Cagliari, Italy
²¹S.C. Ematologia ASST Spedali Civili, Brescia, Italy
²²Hematology Unit, AO Ospedale Civile di Legnano, Legnano, Italy
²³Haematology Unit Santa Maria delle Croci Hospital, Ravenna, Italy
²⁴Section of Hematology, Department of Medicine and Surgery, Center for Hemato-Oncological Research (CREO), University of Perugia, Perugia, Italy
²⁵IRCCS ISTITUTO MARIO NEGRI, Milano, ITA
²⁶ASST Grande Ospedale Metropolitano Niguarda, Niguarda Cancer Center, Department of Hematology, MILANO, MI, Italy

Reid W. Merryman, MD¹, Robert A. Redd, MS^2*, Arnold S. Freedman, MD¹, Inhye E. Ahn, MD¹, Jennifer R. Brown, MD, PhD¹, Jennifer L. Crombie, MD^1*, Matthew S. Davids, MD¹, David C. Fisher, MD^1*, Eric D Jacobsen, MD^1*, Austin I. Kim, MD¹, Ann S. LaCasce, MD¹, Samuel Ng, MD, PhD^1*, Oreofe O. Odejide, MD, MPH¹, Erin Michelle Parry, MD, PhD¹, Iris Isufi, MD³, Justin Kline, MD⁴, Jonathon B. Cohen, MD, MS⁵, Neha Mehta-Shah, MD, MSCI⁶, Nancy L. Bartlett, MD⁶, Matthew Mei, MD⁷, Philippe Armand, MD, PhD^1* and Caron A. Jacobson, MD¹

¹Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
²Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
³Hematology, Yale University School of Medicine, New Haven, CT
⁴Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL
⁵Winship Cancer Institute, Department of Hematology and Medical Oncology, Emory University, Atlanta, GA
⁶Division of Oncology, Washington University School of Medicine, St. Louis, MO
⁷Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Medical Center, Duarte, CA

Shimrit Harlev^1*, Nashwa Fadaos^2*, Tehila Azoulay^3*, Ronit Leiba^4*, Nurit Horesh, MD^1*, Tsofia Inbar, MD^5*, Netanel A. Horowitz^1,2*, Inna Tzoran, MD^1,2*, Noa Lavi, MD^1,2*, Eldad J. Dann, MD^2,6 and Tsila Zuckerman, MD^1,2

¹Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel
²The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel
³Hematology Laboratory, Rambam Health Care Campus, Haifa, Israel
⁴Department of Statistics, Rambam Health Care Campus, Haifa, Israel
⁵Blood Bank and Apheresis Unit, Rambam Health Care Campus, Haifa, Israel
⁶Blood Bank and Apheresis Unit, Rambam Medical Center Blood Bank, Haifa, Haifa, Israel

Kannadit Prayongratana, MD^1*, Tanapun Thamgrang, MD^2*, Lalita Norasetthada, MD³, Thanawat Rattanathammethee, MD^4*, Udomsak Bunworasate, MD^5*, Kitsada Wudhikarn^6*, Arnuparp Lekhakula, MD, MS^7*, Jakrawadee Julamanee, MD, PhD^8*, Suporn Chuncharunee, MD⁹, Pimjai Niparuck, MD^9*, Noppadol Siritanaratanakul^10*, Archrob Khuhapinant, MD¹¹, Piyapong Kanya, MD^12*, Kanchana Chansung, MD^13*, Chittima Sirijerachai, MD^13*, Dusit Jit-Uaekul^14*, Juthatip Chaloemwong, MD^12*, Nonglak Kanitsap, MD^15*, Peerapon Wong, MD^16*, Nisa Makruasi, MD^17*, Somchai Wongkhantee, MD^18*, Tawatchai Suwanban, M.D.^19* and Tanin Intragumtornchai, MD, MSc^20*

¹Division of Hematology, Department of Medicine, Phramongkutklao Hospital College of Medicine, Bangkok, Thailand
²Division of Hematology, Department of Medicine, Phramongkutklao Hospital, Bangkok, NAKHON PATHOM, Thailand
³Division of Hematology, Department of Internal Medicine, Faculty of Med., Chiang Mai University, Chiang mai, Thailand
⁴Division of Hematology, Department of Internal Medicine, Chiang Mai University, Chiang Mai, Thailand
⁵Division of Hematology, Department of Medicine, King Chulalongkorn Memorial Hospital, Bangkok, Thailand
⁶Blood and Marrow Transplantation Program, Chulalongkorn University, Bangkok, Thailand
⁷Division of Hematology, Department of Internal Medicine, Songklanagarind hospital, Songkhla Province, Thailand
⁸Stem Cell Laboratory, Hematology Unit, Division of Internal Medicice, Faculty of Medicine, Prince of Songkla University, Songkhla, AL, Thailand
⁹Division of Hematology, Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
¹⁰Department of Medicine, Faculty of Medicine, Siriraj Hospital, Bangkok, Thailand
¹¹Division of Hematology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
¹²Chiang Mai University, Chiang Mai, Thailand
¹³Division of Hematology, Department of Medicine, Khonkaen University, Khonkaen, Thailand
¹⁴Faculty of Medicine Vajira Hospital., Bangkok, Thailand
¹⁵Department of Medicine, Faculty of Medicine, Thammasat University, Pathumthani, Thailand
¹⁶Division of Hematology, Department of Medicine, Naresuan University, Phitsanulok, Thailand
¹⁷Srinakarinwirot University, Nakhonnayok, THA
¹⁸Division of Hematology, Department of Medicine, Khon Kaen Regional Hospital, Khon Kaen, Thailand
¹⁹Division of Hematology, Department of Medicine, Rajavithi Hospital, Bangkok, Thailand
²⁰Division of Hematology, Department of Medicine, Chulalongkorn University, Bangkok, Thailand